financial groups to maintain minimum levels of capital adequacy as measured by three ratios, including the Common Equity Tier 1 ratio at no less than 4.50 percent, the Tier 1 ratio at no less than 6.00

ratios stood at 68.47% and 72.47%, respectively. The higher ratio on a year-on-year basis was attributable to the Company having some costs in depreciation, personnel, drugs and medical supplies

December 31, 2019, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 71.17% and 68.84%, respectively. The lower ratio on a year-on-year basis was attributable to the Company

million in the year ended 31 December 2016 and the year ended 31 December 2017, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 65.69% and 66.64%, respectively. The

six-month period ended June 30, 2020, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 68.97% and 72.06% , respectively. The higher ratio on a period-on-period basis

failure to prepare and submit (1) the interim financial statements for the six-month period ended 30 June 2023 (2) the audited financial statements for the year 2023 (3) the key financial ratios for the

134.79 million in the six-month period ended June 30, 2016 and the six-month period ended June 30, 2017, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 66.29% and 67.95

, respectively. Meanwhile, the cost of hospital operations to revenue ratios stood at 67.15% and 68.41%, respectively. The higher ratio on a period-on-period basis was attributable to the Company has some fixed

.The increase in financial expenses 25.84 percent increase compared to the same period last year. As a result, net income (loss), net decreased. 5.Significant financial ratios Consists of  The liquidity

owners of the parent 888 783 13.4% 789 12.6% Key Ratios (%) Gross profit margin 34.8% 32.1% 2.7% 34.5% 0.3% SG&A to net sales ratio 20.8% 20.7% 0.1% 21.1% -0.3% EBIT margin 17.3% 15.9% 1.4% 16.9% 0.4